CA Patent

CA2778301C — Compositions comprising palonosetron and netupitant for treating nausea and vomiting

Assigned to Helsinn Healthcare SA · Expires 2016-06-14 · 10y expired

What this patent protects

Provided are combinations of netupitant, or a pharmaceutically acceptable salt thereof, and palonosetron, or a pharmaceutically acceptable salt thereof, which may be used for the treatment or prevention of nausea and vomiting.

USPTO Abstract

Provided are combinations of netupitant, or a pharmaceutically acceptable salt thereof, and palonosetron, or a pharmaceutically acceptable salt thereof, which may be used for the treatment or prevention of nausea and vomiting.

Drugs covered by this patent

Patent Metadata

Patent number
CA2778301C
Jurisdiction
CA
Classification
—
Expires
2016-06-14
Drug substance claim
No
Drug product claim
No
Assignee
Helsinn Healthcare SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.